탭메뉴
| 번호 | 구분 | 제목 |
|---|---|---|
| 283 | (국외)SCIE | High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer |
| 282 | (국외)SCIE | Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer |
| 281 | (국외)SCIE | Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients |
| 280 | (국외)SCIE | Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach |
| 279 | (국외)SCIE | Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study |
| 278 | (국외)SCIE | Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events |
| 277 | (국외)SCIE | Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors |
| 276 | (국외)SCIE | Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis |
| 275 | (국내)SCI | A Prognostic Model to Facilitate Palliative Care Referral in Oncology Outpatients |
| 274 | (국내)KCI | Colonic Perforation After Treatment With Nivolumab in Esophageal Cancer: A Case Report |
Copyright ⓒ chamc, All rights reserved.
